title: Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
authors.forename: Andrea
authors.initials: A
authors.lastname: Calcagno
authors.forename: Silvia
authors.initials: S
authors.lastname: Nozza
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
authors.forename: Antonella
authors.initials: A
authors.lastname: Castagna
authors.forename: Daniel
authors.initials: D
authors.lastname: Gonzalez de Requena
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Avolio
authors.forename: Adriano
authors.initials: A
authors.lastname: Lazzarin
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D003510:Cyclohexanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D009570:Nitriles; D011724:Pyridazines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011743:Pyrimidines; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000068898:Raltegravir Potassium; D016879:Salvage Therapy / Q000379:methods; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; D014230:Triazoles; C451734:etravirine; D000068898:Raltegravir Potassium; D000077592:Maraviroc